JAKKS Pacific Stock News

Jakks (JAKK) made it through our 'Fast-Paced Momentum at a Bargain' screen and could be a great choice for investors looking for stocks that have gained strong momentum recently but are still trading

JAKKS Pacific (JAKK) benefits from strategic acquisitions, a solid international footprint, focus on innovation, and collaborations with popular brands and movie franchisees.

Jakks (JAKK) made it through our 'Fast-Paced Momentum at a Bargain' screen and could be a great choice for investors looking for stocks that have gained strong momentum recently but are still trading

HTLD, VIPS and JAKK made it to the Zacks Rank #1 (Strong Buy) momentum stocks list on August 25, 2022.

JAKK, CIXX and FBP made it to the Zacks Rank #1 (Strong Buy) value stocks list on August 25, 2022.

Gainers MMTec, Inc. (NASDAQ: MTC) shares gained 390.6% to close at $7.85 on Tuesday amid volatility in nano-cap Chinese stocks. Applied DNA Sciences, Inc. (NASDAQ: APDN) surged 296.9% to settle at $2

Gainers AMTD IDEA Group (NYSE: AMTD) shares jumped 284% to $8.00 after jumping 18% on Monday. The company owns 90%+ of AMTD Digital. Applied DNA Sciences, Inc. (NASDAQ: APDN) gained 166% to $1.8801

JAKKS Pacific has just released expectation surpassing Q2 2022 results. Adjusted EBITDA is now $27.1 million versus $5.0 million in Q2 2021. Strong performance connected to strategic blockbuster licen

Gainers Athersys, Inc. (NASDAQ: ATHX) climbed 71.1% to close at $0.3250 on Thursday after gaining 10% on Wednesday. Athersys is expected to release its Q2 financial results on Thursday, August 11, 20

U.S. stocks closed higher on Thursday, with the Dow Jones jumping more than 300 points. Here is the list of some big stocks moving higher in the previous session. JAKKS Pacific, Inc. (NASDAQ: JAKK)

U.S. stocks traded higher toward the end of trading, with the Nasdaq Composite gaining more than 100 points on Thursday. The Dow traded up 1.06% to 32,539.63 while the NASDAQ rose 0.91% to 12,142.14.

Gainers Petros Pharmaceuticals, Inc. (NASDAQ: PTPI) gained 231% to $2.63 on news that the company will be acquired By Henry Crown and Company for $3.25 per share. Petros Pharmaceuticals, however, con

U.S. stocks traded higher midway through trading, with the Dow Jones gaining more than 200 points on Thursday. The Dow traded up 0.67% to 32,412.36 while the NASDAQ rose 0.39% to 12,079.66. The S&P al

U.S. stocks traded lower this morning, with the Nasdaq Composite falling more than 100 points on Thursday. Following the market opening Thursday, the Dow traded down 0.55% to 32,020.44 while the NASDA

JAKKS Pacific's (JAKK) second-quarter 2022 results benefit from robust demand for its products.